How Softgel and Zydis® Platforms Enable Lifecycle Strategies and Product Differentiation

How Softgel and Zydis® Platforms Enable Lifecycle Strategies and Product Differentiation

Thursday, October 30, 2025 11:45 AM to 12:10 PM · 25 min. (Africa/Abidjan)

Hall 4.1 - 4.1L8

Manufacturing 5.0

Information

As global pharmaceutical markets evolve, Lifecycle Management (LCM) is no longer optional, it’s strategic. This session explores how softgel and Zydis® technologies offer a modern platform for revitalizing mature assets, enhancing bioavailability, and improving patient-centricity. Learn how Catalent’s global network and expertise deliver rapid reformulation, scalable manufacturing, and market differentiation—backed by case studies ranging from Rx-to-OTC switches to oncology transformations.

CatalentCatalent is a leading global CDMO whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually.

Speakers

Karu Sukuru

Registered attendees

Aliya Bimukanova

International Marketing Manager Vitamin D/ IbufenPolpharma S.A.

Anke Hollnagel

Senior Director Sales & MarketingGalvita AG

Sales LeaderFARRAR

Log in

See all the content and easy-to-use features by logging in or registering!